Thyrocare Technologies moves up on launching blood-based cancer screening profile

17 Feb 2020 Evaluate

Thyrocare Technologies is currently trading at Rs. 623.00, up by 13.00 points or 2.13% from its previous closing of Rs. 610.00 on the BSE.

The scrip opened at Rs. 615.00 and has touched a high and low of Rs. 634.65 and Rs. 612.50 respectively. So far 6884 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 689.45 on 04-Feb-2020 and a 52 week low of Rs. 406.65 on 31-Jul-2019.

Last one week high and low of the scrip stood at Rs. 637 and Rs. 581.15 respectively. The current market cap of the company is Rs. 3291.71 crore.

The promoters holding in the company stood at 66.01%, while Institutions and Non-Institutions held 25.59% and 8.39% respectively.

Thyrocare Technologies is launching Blood-based Cancer Screening Profile. This consists of Easycheck360, a cancer screening test profile for early detection of 16 types of cancers, processed by Datar Cancer Genetics (Dater) and Thyrocare's popular wellness profile Aarogyam which is available for Rs 8,999.

Cancer screening through blood is a breakthrough and patented technology, pioneered by 'Dater' which is clinically proven in the world's largest study with over 44,000 subjects. The research data has been published and acknowledged by the International Journal of Cancer and other leading cancer journals.

Thyrocare Technologies provides hospital services and are the industry leader, trend setter and innovators in Indian Diagnostic industry.


Thyrocare Tech. Share Price

922.20 -26.85 (-2.83%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7000.00
Max Healthcare Inst 1008.35
Narayana Hrudayalay 1265.30
Aster DM Healthcare 442.70
Global Health 1105.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.